Calcium phosphate cement in the surgical management of benign bone tumors

12Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: This study assessed the mid- to long-term outcomes of calcium phosphate cement (CPC) implantation in benign bone tumor surgery. Patients and Methods: Between 2000 and 2015, 130 patients underwent CPC implantation in benign bone tumor surgery. Radiographic findings and clinical outcomes were retrospectively evaluated. Results: The mean follow-up period was 52 months. CPC filling immediately after surgery was sufficient, regardless of the amount of CPC used and the usage of adjuvant substances, which resulted in 92% of the patients’ radiological results being classified as good or excellent. Significantly more patients had better CPC filling among patients with less hemorrhage and patients with tourniquet. The number of patients with good or excellent CPC filling had significantly increased by the final followup. Conclusion: CPC is a useful bone substitute for benign bone tumor surgery providing excellent osteoconductivity and long-lasting stability without internal fixation.

Cite

CITATION STYLE

APA

Higuchi, T., Yamamoto, N., Hayashi, K., Takeuchi, A., Kimura, H., Miwa, S., … Tsuchiya, H. (2018). Calcium phosphate cement in the surgical management of benign bone tumors. Anticancer Research, 38(5), 3031–3035. https://doi.org/10.21873/anticanres.12558

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free